التفاصيل البيبلوغرافية
| العنوان: |
Tubular Carcinoma of the Breast: The Possibility to Omit Sentinel Lymph Node Biopsy. |
| المؤلفون: |
SAE YAMANE, AKIRA MATSUI, AYAKO NAKASHOJI, SASAHARA, MANAMI, YUYA MURATA, TAKAYUKI KINOSHITA |
| المصدر: |
Cancer Diagnosis & Prognosis; Jul/Aug2024, Vol. 4 Issue 4, p434-440, 7p |
| مصطلحات موضوعية: |
SENTINEL lymph node biopsy, SENTINEL lymph nodes, LOBULAR carcinoma, CARCINOMA in situ, CARCINOMA, RENAL tubular transport disorders, LYMPHATIC metastasis |
| مستخلص: |
Background/Aim: Tubular breast carcinoma, classified as a special type of invasive cancer, has a good prognosis. This study aimed to retrospectively investigate the clinical and pathological characteristics of 32 tubular carcinoma cases enrolled at our institution, with a focus on exploring the potential for treatment de-escalation. Patients and Methods: The study included all patients diagnosed with tubular breast carcinoma at our hospital between January 2005 and December 2021. In addition, 549 patients with ductal carcinoma in situ (DCIS) and 1,524 patients with stage I and II invasive cancers [not otherwise specified (NOS)] were selected for comparison. Results: All participants were female, with an average age of 54.4 years. The median follow-up duration was 64 months. The median tumor diameter was 7 mm, and all cases were Luminal A type. Moreover, no lymph vascular invasion was observed in any case, and no local recurrence, distant metastasis, or death occurred. The sentinel lymph node positive rate was 0% in the tubular carcinoma group, significantly lower than that in the NOS group (25.5%, p=0.0019) and not significantly different from that in the DCIS group (0.2%). The tubular carcinoma group tended to have better overall survival (OS) and disease-free survival (DFS) than the NOS group. Furthermore, the tubular carcinoma group was not inferior in OS and DFS compared to the DCIS group. Conclusion: Lymph node metastasis rate, OS, and DFS of the tubular carcinoma group are comparable to those of the DCIS group. Sentinel lymph node biopsy for tubular carcinoma can be omitted with an accurate preoperative diagnosis. [ABSTRACT FROM AUTHOR] |
|
Copyright of Cancer Diagnosis & Prognosis is the property of International Institute of Anticancer Research and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
